Report cover image

Antibiotic Resistance Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War

Publisher Prodture
Published Aug 16, 2024
Length 116 Pages
SKU # PROD19315418

Description

Antibiotic Resistance Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War


The global antibiotic resistance market is expected to grow at a CAGR of around 5.1% during 2025-2034. This report on global antibiotic resistance market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global antibiotic resistance market by segmenting the market based on disease, pathogen, drug class, distribution channel, and region. Also, detailed profiles of companies operating in the antibiotic resistance market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Drivers

• Rising Government Initiatives
• Growing Developments in the Industry

Market Challenges

• Lack of Skilled Professionals

Historical & Forecast Period

Base Year: 2024
Historical Period: 2020-2024
Forecast Period: 2025-2034

Market by Disease

• Complicated Urinary Tract Infections
• Clostridioides Difficile Infection
• Acute Bacterial Skin and Skin Structure Infections
• Hospital-acquired bacterial Pneumonia
• Community-acquired Pneumonia
• Complicated intra-abdominal Infection
• Bloodstream Infection

Market by Pathogen

• Staphylococcus Aureis
• Streptococcus Pheumoniae
• Acinetobacter
• Enterococcus
• Hemophilus Influenzae

Market by Drug Class

• Oxazolidinones
• Lipoglycopeptides
• Tetracyclines
• Combination Therapies
• Cephalosporins
• Others

Market by Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Market by Region

• Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherlands
Rest of Europe
• North America
United States
Canada
• Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Rest of Asia Pacific
• Latin America
Mexico
Brazil
Argentina
Rest of Latin America
• Middle East & Africa
Saudi Arabia
Turkey
Iran
United Arab Emirates
Rest of Middle East & Africa

Table of Contents

116 Pages
1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Antibiotic Resistance Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Antibiotic Resistance Market Analysis
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
4.5. Impact of Russia-Ukraine War
5. Global Antibiotic Resistance Market by Disease
5.1. Introduction
5.2. Complicated Urinary Tract Infections
5.3. Clostridioides Difficile Infection
5.4. Acute Bacterial Skin and Skin Structure Infections
5.5. Hospital-acquired bacterial Pneumonia
5.6. Community-acquired Pneumonia
5.7. Complicated intra-abdominal Infection
5.8. Bloodstream Infection
6. Global Antibiotic Resistance Market by Pathogen
6.1. Introduction
6.2. Staphylococcus Aureis
6.3. Streptococcus Pheumoniae
6.4. Acinetobacter
6.5. Enterococcus
6.6. Hemophilus Influenzae
7. Global Antibiotic Resistance Market by Drug Class
7.1. Introduction
7.2. Oxazolidinones
7.3. Lipoglycopeptides
7.4. Tetracyclines
7.5. Combination therapies
7.6. Cephalosporins
7.7. Others
8. Global Antibiotic Resistance Market by Distribution Channel
8.1. Food and Beverages
8.2. Hospital Pharmacies
8.3. Retail Pharmacies
8.4. Online Pharmacies
9. Global Antibiotic Resistance Market by Region
9.1. Introduction
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Russia
9.2.7. Netherlands
9.2.8. Rest of the Europe
9.3. North America
9.3.1. United States
9.3.2. Canada
9.4. Asia Pacific
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. South Korea
9.4.5. Australia
9.4.6. Indonesia
9.4.7. Rest of the Asia Pacific
9.5. Latin America
9.5.1. Mexico
9.5.2. Brazil
9.5.3. Argentina
9.5.4. Rest of Latin America
9.6. Middle East & Africa
9.6.1. Saudi Arabia
9.6.2. Turkey
9.6.3. Iran
9.6.4. United Arab Emirates
9.6.5. Rest of Middle East & Africa
10. SWOT Analysis
11. Porter’s Five Forces
12. Market Value Chain Analysis
13. Competitive Landscape
13.1. Competitive Scenario
13.2. Company Profiles
13.2.1. AbbVie Inc
13.2.2. Allergan
13.2.3. Basilea Pharmaceutica Ltd.
13.2.4. Entasis therapeutics
13.2.5. GlaxoSmithKline Plc
13.2.6. Melinta Therapeutics
13.2.7. Merck & Co. Inc.
13.2.8. Nemesis Bioscience Ltd
13.2.9. Novartis AG
13.2.10. Paratek Pharmaceuticals, Inc.
13.2.11. Pfizer Inc
13.2.12. Seres Therapeutics
13.2.13. Tetraphase Pharmaceuticals
13.2.14. Theravance Biopharma
13.2.15. Vertex Pharmaceuticals Incorporated
List of Figures
Figure 1: Global Antibiotic Resistance Market (in US$ Million), 2020-2024
Figure 2: Global Antibiotic Resistance Market by Disease, 2024
Figure 3: Global Antibiotic Resistance Market by Pathogen, 2024
Figure 4: Global Antibiotic Resistance Market by Drug Class, 2024
Figure 5: Global Antibiotic Resistance Market by Distribution Channel, 2024
Figure 6: Global Antibiotic Resistance Market by Region, 2024
Figure 7: Global Antibiotic Resistance Market (in US$ Million), 2025-2034
Figure 8: Global Antibiotic Resistance Market by Disease (in %), 2024 & 2034
Figure 9: Global Complicated Urinary Tract Infections Antibiotic Resistance Market (in US$ Million), 2020-2024
Figure 10: Global Complicated Urinary Tract Infections Antibiotic Resistance Market (in US$ Million), 2025-2034
Figure 11: Global Clostridioides Difficile Infection Antibiotic Resistance Market (in US$ Million), 2020-2024
Figure 12: Global Clostridioides Difficile Infection Antibiotic Resistance Market (in US$ Million), 2025-2034
Figure 13: Global Acute Bacterial Skin and Skin Structure Infections Antibiotic Resistance Market (in US$ Million), 2020-2024
Figure 14: Global Acute Bacterial Skin and Skin Structure Infections Antibiotic Resistance Market (in US$ Million), 2025-2034
Figure 15: Global Hospital-acquired bacterial Pneumonia Antibiotic Resistance Market (in US$ Million), 2020-2024
Figure 16: Global Hospital-acquired bacterial Pneumonia Antibiotic Resistance Market (in US$ Million), 2025-2034
Figure 17: Global Community-acquired Pneumonia Antibiotic Resistance Market (in US$ Million), 2020-2024
Figure 18: Global Community-acquired Pneumonia Antibiotic Resistance Market (in US$ Million), 2025-2034
Figure 19: Global Complicated intra-abdominal Infection Antibiotic Resistance Market (in US$ Million), 2020-2024
Figure 20: Global Complicated intra-abdominal Infection Antibiotic Resistance Market (in US$ Million), 2025-2034
Figure 21: Global Bloodstream Infection Antibiotic Resistance Market (in US$ Million), 2020-2024
Figure 22: Global Bloodstream Infection Antibiotic Resistance Market (in US$ Million), 2025-2034
Figure 23: Global Antibiotic Resistance Market by Pathogen (in %), 2024 & 2034
Figure 24: Global Staphylococcus Aureis Antibiotic Resistance Market (in US$ Million), 2020-2024
Figure 25: Global Staphylococcus Aureis Antibiotic Resistance Market (in US$ Million), 2025-2034
Figure 26: Global Streptococcus Pheumoniae Antibiotic Resistance Market (in US$ Million), 2020-2024
Figure 27: Global Streptococcus Pheumoniae Antibiotic Resistance Market (in US$ Million), 2025-2034
Figure 28: Global Acinetobacter Antibiotic Resistance Market (in US$ Million), 2020-2024
Figure 29: Global Acinetobacter Antibiotic Resistance Market (in US$ Million), 2025-2034
Figure 30: Global Enterococcus Antibiotic Resistance Market (in US$ Million), 2020-2024
Figure 31: Global Enterococcus Antibiotic Resistance Market (in US$ Million), 2025-2034
Figure 32: Global Hemophilus Influenzae Antibiotic Resistance Market (in US$ Million), 2020-2024
Figure 33: Global Hemophilus Influenzae Antibiotic Resistance Market (in US$ Million), 2025-2034
Figure 34: Global Antibiotic Resistance Market by Drug Class (in %), 2024 & 2034
Figure 35: Global Oxazolidinones Antibiotic Resistance Market (in US$ Million), 2020-2024
Figure 36: Global Oxazolidinones Antibiotic Resistance Market (in US$ Million), 2025-2034
Figure 37: Global Lipoglycopeptides Antibiotic Resistance Market (in US$ Million), 2020-2024
Figure 38: Global Lipoglycopeptides Antibiotic Resistance Market (in US$ Million), 2025-2034
Figure 39: Global Tetracyclines Antibiotic Resistance Market (in US$ Million), 2020-2024
Figure 40: Global Tetracyclines Antibiotic Resistance Market (in US$ Million), 2025-2034
Figure 41: Global Combination Therapies Antibiotic Resistance Market (in US$ Million), 2020-2024
Figure 42: Global Combination Therapies Antibiotic Resistance Market (in US$ Million), 2025-2034
Figure 43: Global Cephalosporins Therapies Antibiotic Resistance Market (in US$ Million), 2020-2024
Figure 44: Global Cephalosporins Therapies Antibiotic Resistance Market (in US$ Million), 2025-2034
Figure 45: Global Other Drug Class Antibiotic Resistance Market (in US$ Million), 2020-2024
Figure 46: Global Other Drug Class Antibiotic Resistance Market (in US$ Million), 2025-2034
Figure 47: Global Antibiotic Resistance Market by Distribution Channel (in %), 2024 & 2034
Figure 48: Global Hospital Pharmacies Antibiotic Resistance Market (in US$ Million), 2020-2024
Figure 49: Global Hospital Pharmacies Antibiotic Resistance Market (in US$ Million), 2025-2034
Figure 50: Global Retail Pharmacies Antibiotic Resistance Market (in US$ Million), 2020-2024
Figure 51: Global Retail Pharmacies Antibiotic Resistance Market (in US$ Million), 2025-2034
Figure 52: Global Online Pharmacies Antibiotic Resistance Market (in US$ Million), 2020-2024
Figure 53: Global Online Pharmacies Antibiotic Resistance Market (in US$ Million), 2025-2034
Figure 54: Global Antibiotic Resistance Market by Region (in %), 2024 & 2034
Figure 55: Europe Antibiotic Resistance Market (in US$ Million), 2020-2024
Figure 56: Europe Antibiotic Resistance Market (in US$ Million), 2025-2034
Figure 57: Europe Antibiotic Resistance Market by Country (in %), 2024 & 2034
Figure 58: Germany Antibiotic Resistance Market (in US$ Million), 2020-2034
Figure 59: United Kingdom Antibiotic Resistance Market (in US$ Million), 2020-2034
Figure 60: France Antibiotic Resistance Market (in US$ Million), 2020-2034
Figure 61: Italy Antibiotic Resistance Market (in US$ Million), 2020-2034
Figure 62: Spain Antibiotic Resistance Market (in US$ Million), 2020-2034
Figure 63: Russia Antibiotic Resistance Market (in US$ Million), 2020-2034
Figure 64: Netherlands Antibiotic Resistance Market (in US$ Million), 2020-2034
Figure 65: North America Antibiotic Resistance Market (in US$ Million), 2020-2024
Figure 66: North America Antibiotic Resistance Market (in US$ Million), 2025-2034
Figure 67: North America Antibiotic Resistance Market by Country (in %), 2024 & 2034
Figure 68: United States Antibiotic Resistance Market (in US$ Million), 2020-2034
Figure 69: Canada Antibiotic Resistance Market (in US$ Million), 2020-2034
Figure 70: Asia Pacific Antibiotic Resistance Market (in US$ Million), 2020-2024
Figure 71: Asia Pacific Antibiotic Resistance Market (in US$ Million), 2025-2034
Figure 72: Asia Pacific Antibiotic Resistance Market by Country (in %), 2024 & 2034
Figure 73: China Antibiotic Resistance Market (in US$ Million), 2020-2034
Figure 74: Japan Antibiotic Resistance Market (in US$ Million), 2020-2034
Figure 75: India Antibiotic Resistance Market (in US$ Million), 2020-2034
Figure 76: South Korea Antibiotic Resistance Market (in US$ Million), 2020-2034
Figure 77: Australia Antibiotic Resistance Market (in US$ Million), 2020-2034
Figure 78: Indonesia Antibiotic Resistance Market (in US$ Million), 2020-2034
Figure 79: Latin America Antibiotic Resistance Market (in US$ Million), 2020-2024
Figure 80: Latin America Antibiotic Resistance Market (in US$ Million), 2025-2034
Figure 81: Latin America Antibiotic Resistance Market by Country (in %), 2024 & 2034
Figure 82: Mexico Antibiotic Resistance Market (in US$ Million), 2020-2034
Figure 83: Brazil Antibiotic Resistance Market (in US$ Million), 2020-2034
Figure 84: Argentina Antibiotic Resistance Market (in US$ Million), 2020-2034
Figure 85: Middle East & Africa Antibiotic Resistance Market (in US$ Million), 2020-2024
Figure 86: Middle East & Africa Antibiotic Resistance Market (in US$ Million), 2025-2034
Figure 87: Middle East & Africa Antibiotic Resistance Market by Country (in %), 2024 & 2034
Figure 88: Saudi Arabia Antibiotic Resistance Market (in US$ Million), 2020-2034
Figure 89: Turkey Antibiotic Resistance Market (in US$ Million), 2020-2034
Figure 90: Iran Antibiotic Resistance Market (in US$ Million), 2020-2034
Figure 91: UAE Antibiotic Resistance Market (in US$ Million), 2020-2034
Figure 92: Market Value Chain
List of Tables
Table 1: Global Antibiotic Resistance Market Portraiture
Table 2: Global Antibiotic Resistance Market by Disease (in US$ Million), 2024 & 2034
Table 3: Global Antibiotic Resistance Market by Pathogen (in US$ Million), 2024 & 2034
Table 4: Global Antibiotic Resistance Market by Drug Class (in US$ Million), 2024 & 2034
Table 5: Global Antibiotic Resistance Market by Distribution Channel (in US$ Million), 2024 & 2034
Table 6: Global Antibiotic Resistance Market by Region (in US$ Million), 2024 & 2034
Table 7: Europe Antibiotic Resistance Market by Country (in US$ Million), 2024 & 2034
Table 8: North America Antibiotic Resistance Market by Country (in US$ Million), 2024 & 2034
Table 9: Asia Pacific Antibiotic Resistance Market by Country (in US$ Million), 2024 & 2034
Table 10: Latin America Antibiotic Resistance Market by Country (in US$ Million), 2024 & 2034
Table 11: Middle East & Africa Antibiotic Resistance Market by Country (in US$ Million), 2024 & 2034
Table 12: List of Key Players

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us